European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report.
EXTON, Pa., Dec. 1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and Canadian Nephrology. The report is based on the results of an on-line survey completed by 200 Nephrologists from...

Ligand Collaborator GlaxoSmithKline Gets FDA OK for Promacta.
HEALTH AND BEAUTY CLOSE-UP-25 November 2008-Ligand Collaborator GlaxoSmithKline Gets FDA OK for Promacta(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Ligand Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of GlaxoSmithKline's (GSK) Promacta (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune...

ROCKWELL MEDICAL ANNOUNCES UPDATED DSMB RESULTS.
Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), Wixom, Mich., a specialty pharma company focused on drug and device development in the renal market, has reported that the independent Data Safety Monitoring Board (DSMB) providing oversight for the SFP Phase II-b iron maintenance therapy dose-range study reviewed the cumulative safety data from...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies.
- Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH - Exjade results at ASH to show benefits for chronically transfused patients by significantly reducing toxic iron that can damage key organs...

Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes.
Randomized Comparator Study to Evaluate Efficacy of Commercially Available Hypomethylating Agents WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswire/ -- Eisai Corporation of North America today announced that it plans to initiate the first clinical trial evaluating the activity of Dacogen(R) (decitabine for injection) compared to Vidaza(R) (azacitidine) in...

U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting.
CAMBRIDGE, Mass., Dec. 2 /PRNewswire-FirstCall/ -- Biopure Corporation announced today that the U.S. Naval Medical Research Center (NMRC) has submitted to the Food and Drug Administration (FDA) a revised investigational new drug (IND) application to conduct a clinical trial of the company's oxygen therapeutic Hemopure(R) [hemoglobin glutamer - 250...

Sequenom Reports Data from Collaborative Project with The Chinese University of Hong Kong.
HEALTH AND BEAUTY CLOSE-UP-27 November 2008-Sequenom Reports Data from Collaborative Project with The Chinese University of Hong Kong(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Sequenom, announced that advanced data from a collaborative project with The Chinese University of Hong Kong, supporting the noninvasive prenatal diagnosis of monogenic diseases, were...

Affymax Advances in Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients.
HEALTH AND BEAUTY CLOSE-UP-7 November 2008-Affymax Advances in Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Affymax announced that enrollment has been completed in the second of four Phase 3 clinical trials of its lead investigational therapy, Hematide, which...

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting.
PHILADELPHIA, Nov. 7 /PRNewswire/ -- Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT(R) (Epoetin alfa) in treating anemia in subjects with Stages 3 - 4 chronic kidney disease (CKD) were presented today at the American Society of Nephrology 41st Annual Meeting. All...